Antisense Oligonucleotides Internally Labeled with Peptides Show Improved Target Recognition and Stability to Enzymatic Degradation
- 1 December 2016
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 28 (3) , 768-774
Abstract
Specific target binding and stability in diverse biological media is of crucial importance for applications of synthetic oligonucleotides as diagnostic and therapeutic tools. So far, these issues have been addressed by chemical modification of oligonucleotides and by conjugation with a peptide, most often at the terminal position of the oligonucleotide. Herein, we for the first time systematically investigate the influence of internally attached short peptides on the properties of antisense oligonucleotides. We report the synthesis and internal double labeling of 21-mer oligonucleotides that target the BRAF V600E oncogene, with a library of rationally designed peptides employing CuAAC “click” chemistry. The peptide sequence has an influence on the specificity and affinity of target DNA/RNA binding. We also investigated the impact of locked nucleic acids (LNAs) on the latter. Lysine residues improve binding of POCs to target DNA and RNA, whereas the distance to lysine correlates exclusively with a decrease in binding of mismatched RNA targets. Glycine and tyrosine residues affect target binding as well. Importantly, the resistance of POCs to enzymatic degradation is dramatically improved by the internal attachment of peptides but not by LNA alone. Independently of the peptide sequence, the conjugates are stable for up to 24 h in 90% human serum and duplexes of POCs with complementary DNA for up to 160 h in 90% human serum. Such excellent stability has not been previously reported for DNA and makes internally labeled POCs an exciting object of study, i.e., showing high target specificity and simultaneous stability in biological media.Keywords
Funding Information
- Villum Fonden (73516, 90-7315)
This publication has 43 references indexed in Scilit:
- Treatment of Metastatic Bone Disease and the Emerging Role of Radium-223Seminars in Nuclear Medicine, 2016
- Y-90 Radiomicrosphere Therapy for Colorectal Cancer Liver MetastasesSeminars in Nuclear Medicine, 2016
- Neuroprotective effect of Decalepis hamiltonii on cyclophosphamide-induced oxidative stress in the mouse brainJournal of Basic and Clinical Physiology and Pharmacology, 2016
- MicroRNA-based therapy and breast cancer: A comprehensive review of novel therapeutic strategies from diagnosis to treatmentPharmacological Research, 2015
- Progress in RNAi-mediated Molecular Therapy of Acute and Chronic Myeloid LeukemiaMolecular Therapy Nucleic Acids, 2015
- siRNA-Based Therapies for Pulmonary DiseasesJournal of Biomedical Nanotechnology, 2014
- MicroRNA Therapeutics in Neurological DiseaseCurrent Pharmaceutical Design, 2014
- Gene therapeutic approaches to inhibit hepatitis B virus replicationWorld Journal of Hepatology, 2014
- State-of-the-art gene-based therapies: the road aheadNature Reviews Genetics, 2011
- LNA and α-L-LNA: Towards Therapeutic ApplicationsNucleosides, Nucleotides & Nucleic Acids, 2003